Sales Support
U.S.:+1-415-871-0703
U.K.:+44-203-289-4040
AUS.: +61-2-4786-0457
INDIA:+91-848-285-0837
Contact Us
We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

Global Antibody Drug Conjugates Sales Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2025

  • Purchase Options

 
In this report, the global Antibody Drug Conjugates market is valued at USD XX million in 2019 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2019 and 2025.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Antibody Drug Conjugates for these regions, from 2018 to 2025 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Antibody Drug Conjugates market competition by top manufacturers/players, with Antibody Drug Conjugates sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
F.Hoffman-La Roche
Novartis
Takeda Pharmaceutial
Pfizer
Seattle Genetics
Genentech
Immunogen
Immunomedics
Progenics Pharmaceutical
Bayer Healthcare Pharmaceutical
Agensys
Concortis Biotherapeutics
Sanofi
Celldex Therapeutics
Synthon Holding
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Adcetris
Kadcyla
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Antibody Drug Conjugates for each application, including
Breast Cancer
Lymphoma

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Global Antibody Drug Conjugates Sales Market Report 2019
1 Antibody Drug Conjugates Market Overview
1.1 Product Overview and Scope of Antibody Drug Conjugates
1.2 Classification of Antibody Drug Conjugates by Product Category
1.2.1 Global Antibody Drug Conjugates Market Size (Sales) Comparison by Type (2014-2024)
1.2.2 Global Antibody Drug Conjugates Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Adcetris
1.2.4 Kadcyla
1.3 Global Antibody Drug Conjugates Market by Application/End Users
1.3.1 Global Antibody Drug Conjugates Sales (Volume) and Market Share Comparison by Application (2014-2024)
1.3.2 Breast Cancer
1.3.3 Lymphoma
1.4 Global Antibody Drug Conjugates Market by Region
1.4.1 Global Antibody Drug Conjugates Market Size (Value) Comparison by Region (2014-2024)
1.4.2 United States Antibody Drug Conjugates Status and Prospect (2014-2024)
1.4.3 China Antibody Drug Conjugates Status and Prospect (2014-2024)
1.4.4 Europe Antibody Drug Conjugates Status and Prospect (2014-2024)
1.4.5 Japan Antibody Drug Conjugates Status and Prospect (2014-2024)
1.4.6 Southeast Asia Antibody Drug Conjugates Status and Prospect (2014-2024)
1.4.7 India Antibody Drug Conjugates Status and Prospect (2014-2024)
1.5 Global Market Size (Value and Volume) of Antibody Drug Conjugates (2014-2024)
1.5.1 Global Antibody Drug Conjugates Sales and Growth Rate (2014-2024)
1.5.2 Global Antibody Drug Conjugates Revenue and Growth Rate (2014-2024)

2 Global Antibody Drug Conjugates Competition by Players/Suppliers, Type and Application
2.1 Global Antibody Drug Conjugates Market Competition by Players/Suppliers
2.1.1 Global Antibody Drug Conjugates Sales and Market Share of Key Players/Suppliers (2014-2019)
2.1.2 Global Antibody Drug Conjugates Revenue and Share by Players/Suppliers (2014-2019)
2.2 Global Antibody Drug Conjugates (Volume and Value) by Type
2.2.1 Global Antibody Drug Conjugates Sales and Market Share by Type (2014-2019)
2.2.2 Global Antibody Drug Conjugates Revenue and Market Share by Type (2014-2019)
2.3 Global Antibody Drug Conjugates (Volume and Value) by Region
2.3.1 Global Antibody Drug Conjugates Sales and Market Share by Region (2014-2019)
2.3.2 Global Antibody Drug Conjugates Revenue and Market Share by Region (2014-2019)
2.4 Global Antibody Drug Conjugates (Volume) by Application

3 United States Antibody Drug Conjugates (Volume, Value and Sales Price)
3.1 United States Antibody Drug Conjugates Sales and Value (2014-2019)
3.1.1 United States Antibody Drug Conjugates Sales and Growth Rate (2014-2019)
3.1.2 United States Antibody Drug Conjugates Revenue and Growth Rate (2014-2019)
3.1.3 United States Antibody Drug Conjugates Sales Price Trend (2014-2019)
3.2 United States Antibody Drug Conjugates Sales Volume and Market Share by Players
3.3 United States Antibody Drug Conjugates Sales Volume and Market Share by Type
3.4 United States Antibody Drug Conjugates Sales Volume and Market Share by Application

4 China Antibody Drug Conjugates (Volume, Value and Sales Price)
4.1 China Antibody Drug Conjugates Sales and Value (2014-2019)
4.1.1 China Antibody Drug Conjugates Sales and Growth Rate (2014-2019)
4.1.2 China Antibody Drug Conjugates Revenue and Growth Rate (2014-2019)
4.1.3 China Antibody Drug Conjugates Sales Price Trend (2014-2019)
4.2 China Antibody Drug Conjugates Sales Volume and Market Share by Players
4.3 China Antibody Drug Conjugates Sales Volume and Market Share by Type
4.4 China Antibody Drug Conjugates Sales Volume and Market Share by Application

5 Europe Antibody Drug Conjugates (Volume, Value and Sales Price)
5.1 Europe Antibody Drug Conjugates Sales and Value (2014-2019)
5.1.1 Europe Antibody Drug Conjugates Sales and Growth Rate (2014-2019)
5.1.2 Europe Antibody Drug Conjugates Revenue and Growth Rate (2014-2019)
5.1.3 Europe Antibody Drug Conjugates Sales Price Trend (2014-2019)
5.2 Europe Antibody Drug Conjugates Sales Volume and Market Share by Players
5.3 Europe Antibody Drug Conjugates Sales Volume and Market Share by Type
5.4 Europe Antibody Drug Conjugates Sales Volume and Market Share by Application

6 Japan Antibody Drug Conjugates (Volume, Value and Sales Price)
6.1 Japan Antibody Drug Conjugates Sales and Value (2014-2019)
6.1.1 Japan Antibody Drug Conjugates Sales and Growth Rate (2014-2019)
6.1.2 Japan Antibody Drug Conjugates Revenue and Growth Rate (2014-2019)
6.1.3 Japan Antibody Drug Conjugates Sales Price Trend (2014-2019)
6.2 Japan Antibody Drug Conjugates Sales Volume and Market Share by Players
6.3 Japan Antibody Drug Conjugates Sales Volume and Market Share by Type
6.4 Japan Antibody Drug Conjugates Sales Volume and Market Share by Application

7 Southeast Asia Antibody Drug Conjugates (Volume, Value and Sales Price)
7.1 Southeast Asia Antibody Drug Conjugates Sales and Value (2014-2019)
7.1.1 Southeast Asia Antibody Drug Conjugates Sales and Growth Rate (2014-2019)
7.1.2 Southeast Asia Antibody Drug Conjugates Revenue and Growth Rate (2014-2019)
7.1.3 Southeast Asia Antibody Drug Conjugates Sales Price Trend (2014-2019)
7.2 Southeast Asia Antibody Drug Conjugates Sales Volume and Market Share by Players
7.3 Southeast Asia Antibody Drug Conjugates Sales Volume and Market Share by Type
7.4 Southeast Asia Antibody Drug Conjugates Sales Volume and Market Share by Application

8 India Antibody Drug Conjugates (Volume, Value and Sales Price)
8.1 India Antibody Drug Conjugates Sales and Value (2014-2019)
8.1.1 India Antibody Drug Conjugates Sales and Growth Rate (2014-2019)
8.1.2 India Antibody Drug Conjugates Revenue and Growth Rate (2014-2019)
8.1.3 India Antibody Drug Conjugates Sales Price Trend (2014-2019)
8.2 India Antibody Drug Conjugates Sales Volume and Market Share by Players
8.3 India Antibody Drug Conjugates Sales Volume and Market Share by Type
8.4 India Antibody Drug Conjugates Sales Volume and Market Share by Application

9 Global Antibody Drug Conjugates Players/Suppliers Profiles and Sales Data
9.1 F.Hoffman-La Roche
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Antibody Drug Conjugates Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 F.Hoffman-La Roche Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2014-2019)
9.1.4 Main Business/Business Overview
9.2 Novartis
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Antibody Drug Conjugates Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Novartis Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2014-2019)
9.2.4 Main Business/Business Overview
9.3 Takeda Pharmaceutial
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Antibody Drug Conjugates Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Takeda Pharmaceutial Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2014-2019)
9.3.4 Main Business/Business Overview
9.4 Pfizer
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Antibody Drug Conjugates Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Pfizer Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2014-2019)
9.4.4 Main Business/Business Overview
9.5 Seattle Genetics
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Antibody Drug Conjugates Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Seattle Genetics Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2014-2019)
9.5.4 Main Business/Business Overview
9.6 Genentech
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Antibody Drug Conjugates Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Genentech Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2014-2019)
9.6.4 Main Business/Business Overview
9.7 Immunogen
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Antibody Drug Conjugates Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Immunogen Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2014-2019)
9.7.4 Main Business/Business Overview
9.8 Immunomedics
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Antibody Drug Conjugates Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Immunomedics Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2014-2019)
9.8.4 Main Business/Business Overview
9.9 Progenics Pharmaceutical
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Antibody Drug Conjugates Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Progenics Pharmaceutical Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2014-2019)
9.9.4 Main Business/Business Overview
9.10 Bayer Healthcare Pharmaceutical
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Antibody Drug Conjugates Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Bayer Healthcare Pharmaceutical Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2014-2019)
9.10.4 Main Business/Business Overview
9.11 Agensys
9.12 Concortis Biotherapeutics
9.13 Sanofi
9.14 Celldex Therapeutics
9.15 Synthon Holding

10 Antibody Drug Conjugates Maufacturing Cost Analysis
10.1 Antibody Drug Conjugates Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Antibody Drug Conjugates
10.3 Manufacturing Process Analysis of Antibody Drug Conjugates

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Antibody Drug Conjugates Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Antibody Drug Conjugates Major Manufacturers in 2016
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Antibody Drug Conjugates Market Forecast (2019-2024)
14.1 Global Antibody Drug Conjugates Sales Volume, Revenue and Price Forecast (2019-2024)
14.1.1 Global Antibody Drug Conjugates Sales Volume and Growth Rate Forecast (2019-2024)
14.1.2 Global Antibody Drug Conjugates Revenue and Growth Rate Forecast (2019-2024)
14.1.3 Global Antibody Drug Conjugates Price and Trend Forecast (2019-2024)
14.2 Global Antibody Drug Conjugates Sales Volume, Revenue and Growth Rate Forecast by Region (2019-2024)
14.2.1 Global Antibody Drug Conjugates Sales Volume and Growth Rate Forecast by Regions (2019-2024)
14.2.2 Global Antibody Drug Conjugates Revenue and Growth Rate Forecast by Regions (2019-2024)
14.2.3 United States Antibody Drug Conjugates Sales Volume, Revenue and Growth Rate Forecast (2019-2024)
14.2.4 China Antibody Drug Conjugates Sales Volume, Revenue and Growth Rate Forecast (2019-2024)
14.2.5 Europe Antibody Drug Conjugates Sales Volume, Revenue and Growth Rate Forecast (2019-2024)
14.2.6 Japan Antibody Drug Conjugates Sales Volume, Revenue and Growth Rate Forecast (2019-2024)
14.2.7 Southeast Asia Antibody Drug Conjugates Sales Volume, Revenue and Growth Rate Forecast (2019-2024)
14.2.8 India Antibody Drug Conjugates Sales Volume, Revenue and Growth Rate Forecast (2019-2024)
14.3 Global Antibody Drug Conjugates Sales Volume, Revenue and Price Forecast by Type (2019-2024)
14.3.1 Global Antibody Drug Conjugates Sales Forecast by Type (2019-2024)
14.3.2 Global Antibody Drug Conjugates Revenue Forecast by Type (2019-2024)
14.3.3 Global Antibody Drug Conjugates Price Forecast by Type (2019-2024)
14.4 Global Antibody Drug Conjugates Sales Volume Forecast by Application (2019-2024)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer


 

  • Purchase Options

  • Happy To Assist You

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.

Contact us